Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 129
Filtrar
1.
Urologie ; 63(4): 367-372, 2024 Apr.
Artículo en Alemán | MEDLINE | ID: mdl-38270604

RESUMEN

Penile squamous cell carcinoma is a rare, highly aggressive cancer of older men. The metastatic stage has significant therapeutic and prognostic features. Treatment of penile cancer is significantly influenced by the operation, in which an R0 situation must be achieved to ensure a realistic chance of cure. Other local therapeutic procedures such as radiotherapy are often of secondary importance. Neoadjuvant and adjuvant chemotherapy are relevant components of multimodal therapy. Post-therapeutically, patients require lifelong, risk-adapted follow-up care.


Asunto(s)
Neoplasias del Pene , Masculino , Humanos , Anciano , Neoplasias del Pene/diagnóstico , Escisión del Ganglio Linfático/métodos , Estadificación de Neoplasias , Metástasis Linfática/patología , Ganglios Linfáticos/patología
2.
Urologe A ; 60(7): 886-894, 2021 Jul.
Artículo en Alemán | MEDLINE | ID: mdl-34184100

RESUMEN

Conventional histopathological grading of a cancer is of utmost importance for the management and prognosis of the patient. Histopathological grading is predominantly a function of the differentiation and proliferation of tumor cells, the amount of necrosis present and the pattern of invasion. In addition, the molecular set-up of a given cancer which can be determined to some degree by immunohistochemistry or by methods analyzing genetic and epigenetic alterations can be used in some instances to improve the information gained by conventional histopathologic grading. Indeed, this latter option implies the promise of individualized tumor therapy. While this promise is on the horizon, the clinical implications for penile cancer are not yet transferable to individualized penile cancer treatment.


Asunto(s)
Neoplasias del Pene , Técnicas de Apoyo para la Decisión , Humanos , Inmunohistoquímica , Metástasis Linfática , Masculino , Clasificación del Tumor , Estadificación de Neoplasias , Neoplasias del Pene/patología , Pronóstico
3.
Urologe A ; 59(2): 209-218, 2020 Feb.
Artículo en Alemán | MEDLINE | ID: mdl-32020240

RESUMEN

The incidence of penile cancer in central Europe and North America is low, and patients often present at a late stage of the disease. The diagnosis can very often be made by visual examination of the primary tumor. Its morphology, size, and location as well as the inguinal lymph nodes are of clinical interest. The removal of (micro)metastatic lymph nodes is decisive for the prognosis. These cannot be diagnosed clinically or by imaging with sufficient reliability, which makes invasive lymph node staging necessary. Penile cancer can only be cured by surgery in patients with localized cancer and early stage regional lymph node metastasis. The primary tumor, including metastatic lymph nodes, must be completely excised as early as possible. If indicated, organ preservation must be performed with strict adherence of safety margins. Optimal lymph node management is crucial for long-term survival.


Asunto(s)
Escisión del Ganglio Linfático/métodos , Ganglios Linfáticos/patología , Neoplasias del Pene/diagnóstico , Neoplasias del Pene/cirugía , Supervivencia sin Enfermedad , Europa (Continente) , Humanos , Metástasis Linfática/patología , Metástasis Linfática/prevención & control , Masculino , Estadificación de Neoplasias , Neoplasias del Pene/mortalidad , Neoplasias del Pene/patología , Pene/patología , Pronóstico , Reproducibilidad de los Resultados , Análisis de Supervivencia
4.
Urolithiasis ; 48(1): 47-56, 2020 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-30259058

RESUMEN

Ureteric stents have become an indispensable tool in the armamentarium of every urologist. However, they carry their own morbidity resulting mostly from infectious or abacterial fouling and biofilm formation, and/or urothelial hyperplastic reaction. All of these may interact and lead to clinical complications. Many different stent designs and coatings have been proposed. In this study, we focused on the effect of paclitaxel-coated stents on hyperplastic proliferation of ureteral tissue, using as example anastomotic strictures after ureteroureterostomy in a rat model. Human urothelial cells (SV-HUC-1) were used to determine paclitaxel dosages in vitro. Polyurethane stents were coated with a paclitaxel containing biodegradable polymer and studied in a ureteroureterostomy rat model. 48 male 9-week-old Sprague-Dawley rats underwent either sham surgery (n = 16) or ureteroureterostomy with sutured anastomosis, and consecutive stenting with either a paclitaxel-coated or an uncoated stent (16 per group), respectively. The animals received daily intraperitoneal injections of 5-bromo-2-deoxyuridine (20 mg/ml, 100 mg/kg body weight) during the first eight postoperative days, and were sacrificed on day 28. Healing of the ureteral anastomosis and proliferation of urothelial cells was examined histologically and immunohistochemically. In vitro, a concentration of 10 ng/mm2 paclitaxel can be considered as non-toxic, while still exerting an anti-proliferative effect on urothelial cells. Histologically, typical wound healing processes were seen at the site of the ureteral anastomosis in vivo. Proliferation of urothelial cells was significantly lower in animals with paclitaxel-coated stents compared to those with uncoated stents (LI 41.27 vs. 51.58, p < 0.001). Our results indicate that stenting of ureteral anastomoses with paclitaxel-coated stents can reduce hyperplastic proliferation of ureteral tissue. Paclitaxel-coated stents thus might be able to prevent not only scar-induced postoperative stenosis after reconstructive surgery, but also hyperplastic urothelial reaction in non-anastomotic stent patients as part of their inflammatory response to the foreign material.


Asunto(s)
Stents Liberadores de Fármacos , Paclitaxel/administración & dosificación , Uréter/efectos de los fármacos , Obstrucción Ureteral/terapia , Urotelio/efectos de los fármacos , Animales , Línea Celular , Proliferación Celular/efectos de los fármacos , Modelos Animales de Enfermedad , Células Epiteliales/efectos de los fármacos , Células Epiteliales/patología , Humanos , Hiperplasia/prevención & control , Masculino , Ratas , Uréter/patología , Uréter/cirugía , Urotelio/citología , Urotelio/patología
7.
Urologe A ; 58(10): 1179-1184, 2019 Oct.
Artículo en Alemán | MEDLINE | ID: mdl-31338523

RESUMEN

Religion, which is one of the most important sources of human identity, has so far hardly been taken into account in the clinic. In the largely secularized society of Germany, this has played a highly subordinate role. Currently, however, the development towards a multireligious society is emerging, which will also be reflected in everyday medical care. Disease and mortality in patients can affect different cultural-religious spheres. Although distinction between cultural and religious aspects is possible, it is not necessary for clinical practice. In the situation of oncological therapy, questions may arise which must be answered differently in the religions Christianity, Judaism and Islam and which should be taken into account when selecting therapy. The consideration of cultural-religious rules can intensify the patient's acceptance, but it can also impair it in case of disregard. Such peculiarities can be the separation into male and female spheres or the restriction of certain auxiliary substances or drugs (blood products, narcotics). Kübler-Ross's phase model is suitable for determining where cultural-religious sensitivities should be taken into account in the phases of disease and how cultural-religious offerings can benefit the course of therapy. Due to large individual, regional, cultural and confessional differences, no systematic catalogue of procedures can be provided here. However, knowledge of such differences, more sensitive interaction with patients and their families and cooperation with hospital pastors can strengthen the relationship of trust between doctor and patient and thus improve the conditions for successful oncological therapy. These aspects should not be underestimated when treating people of other faiths in Germany's secular society.


Asunto(s)
Competencia Cultural , Neoplasias/terapia , Religión y Medicina , Religión , Cristianismo , Femenino , Alemania , Humanos , Islamismo , Judaísmo , Masculino , Neoplasias/etnología , Neoplasias/psicología , Espiritualidad
8.
Urologe A ; 58(7): 774-780, 2019 Jul.
Artículo en Alemán | MEDLINE | ID: mdl-31240374

RESUMEN

Due to its low incidence there is only very limited data concerning molecular markers in penile cancer. Recent studies show potential prognostic markers for lymph node metastasis, survival and response to chemotherapy or targeted therapy. Nevertheless the number of patients in the studies is very limited. Therefor clear recommendations for clinical decisions remain very weak. Patients with metastatic disease should be treated in clinical trials with translational biomarker research to improve the molecular tumor board in the future.


Asunto(s)
Biomarcadores de Tumor/genética , Metástasis Linfática/patología , Terapia Molecular Dirigida , Neoplasias del Pene/tratamiento farmacológico , Neoplasias del Pene/genética , Regulación Neoplásica de la Expresión Génica/genética , Genes Supresores de Tumor , Humanos , Escisión del Ganglio Linfático , Ganglios Linfáticos/patología , Masculino , Estadificación de Neoplasias , Neoplasias del Pene/patología , Pronóstico
9.
Urologe A ; 58(8): 885-887, 2019 Aug.
Artículo en Alemán | MEDLINE | ID: mdl-31254014

RESUMEN

The number of organ donations in Germany has continuously fallen in recent years. The proposed Transplantation Act stipulates that every German citizen is considered an organ donor if he/she has not objected during his/her lifetime. This proposal has received wide approval, but also much criticism. The German Society for Urology, the German Society for Surgery, the German Society for Nephrology and the German Transplantation Society have all spoken out in press releases in favor of the introduction of an opt out (presumed consent) solution. The German Bundestag will decide on the proposed bill in autumn.


Asunto(s)
Política de Salud/legislación & jurisprudencia , Legislación Médica , Trasplante de Órganos , Obtención de Tejidos y Órganos , Femenino , Alemania , Humanos , Masculino , Nefrología , Trasplante de Órganos/legislación & jurisprudencia , Sociedades Médicas , Donantes de Tejidos , Obtención de Tejidos y Órganos/legislación & jurisprudencia
10.
Urologe A ; 58(9): 1057-1065, 2019 Sep.
Artículo en Alemán | MEDLINE | ID: mdl-31093717

RESUMEN

BACKGROUND: Histological classification of renal cell carcinoma (RCC) has become more and more important for clinical management, but relatively few is known regarding the swiftness with which the 2016 World Health Organization (WHO) classification of RCC was adopted in the daily routine diagnostics. AIM: To retrospectively review the histological diagnosis of RCC within the context of 2016 WHO classification followed by survival analysis. MATERIAL AND METHODS: Retrospective register based analysis of RCC diagnosis between 1998 and 2017 and survival analysis. RESULTS: 1440 RCC cases were registered between 1998 and 1917. According to 2016 WHO classification, 77.7% clear cell RCC and 22.3% non-clear cell RCC were diagnosed. A total of 37 rare subtypes were recorded, among those 1% MiT family translocation RCC, 0.35% acquired cystic disease-associated RCC, 0.35% multilocular cystic renal neoplasm of low malignant potential, 0.35% collecting duct carcinoma, 0.3% mucinous tubular and spindle cell carcinoma, 0.1% clear cell papillary RCC and 0.1% RCC with (angio)leiomyomatous stroma. Cox regression analysis showed significant different overall survival and progression-free survival between the histological subtypes. DISCUSSION: The complexity of the 2016 WHO classification of RCC put high demands on histopathological diagnostics. At University Medicine Center Rostock morphological distinct RCC entities have been mostly diagnosed by conventional means via hematoxillin and eosin stained slides, but beyond immunohistochemistry additionally molecular techniques were established. The histologic subtyping of RCC according to 2016 WHO classification has prognostic significance and might have predictive significance for unique therapeutic approaches.


Asunto(s)
Carcinoma de Células Renales/diagnóstico , Neoplasias Renales/diagnóstico , Riñón/patología , Carcinoma de Células Renales/clasificación , Carcinoma de Células Renales/patología , Humanos , Inmunohistoquímica , Neoplasias Renales/clasificación , Neoplasias Renales/patología , Pronóstico , Estudios Retrospectivos , Organización Mundial de la Salud
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA